drugset / Trial / NCT03395002

Tiotropium/Salmeterol/Fluticasone Fixed Dose Combination Tratment Via Discair vs Tiotropium Via Handihaler + Salmeterol/Fluticasone Via Diskus Free Combination Treatment

NCT03395002

Phase 4 Completed 58 enrolled Neutec Ar-Ge San ve Tic A.Ş
RandomizedParallel-groupOpen-labelTreatment

Summary

The overall objective is to asses the bronchodilator effect of Tiotropium/Salmeterol/Fluticasone combination delivered via Discair® twice daily as compared with original products Seretide Diskus 500 mcg Inhalation Powder twice daily and Spiriva 18 mcg Inhalation Powder once daily free combination treatment in patients with stable moderate to severe COPD. Spirometric measurements will be performed totally at 15 different time points at pretreatment and post-treatment (pre-dose, 15. min, 30. min, 1. hr, 2. hr, 4.hr, 8.hr and 12.hr) during the first treatment day and at 16 different time points (15. min, 30. min, 1. hr, 2. hr, 4.hr, 6 hr, 8.hr and 12.hr) during the second treatment day.

Timeline

Start
2018-03-22
Primary completion
2020-04-30
Completion
2020-04-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Fluticasone Other / unclassified 500 ug Inhaled
Comparator Salmeterol Other / unclassified 50 ug Inhaled
Comparator Tiotropium Other / unclassified 9 ug Inhaled
Comparator Tiotropium Other / unclassified 18 ug Inhaled